A rare genetic defect that affects the so-called ALG2 gene can cause serious metabolic diseases in humans. Until now, its rareness and complexity made it difficult to study this congenital glycosylation disorder. A research team has finally succeeded in introducing the underlying mutation in the ALG2 gene in a fish model, allowing the causes of these complex diseases to be studied at the molecular level.